As expected, pimecrolimus was well tolerated, the team reports, noting that there were no drug-related serious adverse effects.
与预料一样，吡美莫司耐受性良好，该研究小组指出，吡美莫司没有严重的副作用。
2
Stopping pimecrolimus cream did not lead to a rebound of skin symptoms in most of the patients who entered the follow-up phase, they also report.
该小组也报道指出停用吡美莫司乳膏并不会导致随访期患者皮肤症状反弹。
3
Pimecrolimus was most effective in patients with corticosteroid-induced POD. Pimecrolimus-treated patients reported greater gains in quality of life than control-treated patients.